Invex Therapeutics (ASX:IXC) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics Dividend Payout Ratio?

Invex Therapeutics's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Invex Therapeutics's Dividend Payout Ratio or its related term are showing as below:

ASX:IXC's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-26), the Dividend Yield % of Invex Therapeutics is 221.79%.

During the past 4 years, the highest Trailing Annual Dividend Yield of Invex Therapeutics was 262.39%. The lowest was 0.00%. And the median was 0.00%.

Invex Therapeutics's Dividends per Share for the months ended in Dec. 2023 was A$0.19.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Invex Therapeutics Dividend Payout Ratio Historical Data

The historical data trend for Invex Therapeutics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invex Therapeutics Dividend Payout Ratio Chart

Invex Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Dividend Payout Ratio

Invex Therapeutics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Invex Therapeutics's Dividend Payout Ratio

For the Biotechnology subindustry, Invex Therapeutics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invex Therapeutics's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Invex Therapeutics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Invex Therapeutics's Dividend Payout Ratio falls into.

Invex Therapeutics Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Invex Therapeutics's Dividend Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jun. 2023 )	/	EPS without NRI (A: Jun. 2023 )
	=	0	/	-0.103
	=	N/A

Invex Therapeutics's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0.186	/	-0.028
	=	N/A

Invex Therapeutics (ASX:IXC) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Invex Therapeutics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Invex Therapeutics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Invex Therapeutics (ASX:IXC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008

Website

https://www.invextherapeutics.com

Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its other program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.